Want to join the conversation?
Filtration products company $CLC reported net income of $53.3MM or $1.09 per share in 2Q16, an increase of $0.33 per share versus $38.5MM or $0.76 per share in 2Q15. The increase was driven by a $0.37 per diluted share benefit from the patent litigation award. Net sales declined 9% to $365MM compared to last year.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?